Literature DB >> 24696796

Laparoscopic approach to a large ovarian fibroma: a case report.

Zahra Najmi1, Abolfazl Mehdizadehkashi2, Maryam Kadivar3, Zeinab Tamannaie1, Shahla Chaichian4.   

Abstract

BACKGROUND: Ovarian fibroma is the most common benign solid tumor of the ovary, which is often difficult to diagnose preoperatively. The choice treatment for ovarian fibroma is surgical removal, but discussions for the operative approach, laparoscopic or open, in the literature seem to be scant. CASE
PRESENTATION: We presented a unique clinical experience of laparoscopic approach to a case of 15 cm unilateral ovarian fibroma in a 24 year old patient, with a successful and complete resection of the tumor beside ovarian tissue preservation in December 2012 in Rasoul-e-Akram hospital, Tehran, Iran.
CONCLUSION: In conclusion, we should not forget the role of laparoscopy as a diagnostic procedure even in suspicious cases of ovarian fibroma with solid tumor, ascites, and pleural effusion.

Entities:  

Keywords:  Benign ovarian neoplasm; Laparoscopy; Ovarian fibroma; Thecoma

Year:  2014        PMID: 24696796      PMCID: PMC3955425     

Source DB:  PubMed          Journal:  J Reprod Infertil        ISSN: 2228-5482


Introduction

Ovarian fibroma is a solid tumor that belongs to sex-cord stromal cell tumors of the ovary and comprises spindle shape fibroblastic cells and abundant collagen (1, 2). Furthermore they are the most common benign solid tumors of the ovary, which account for 1 − 4% of benign ovarian tumors (1, 3, 4). Ovarian fibroma is often difficult to diagnose preoperatively and usually misdiagnosed as uterine myoma, because of the solid nature of the mass on examination, and the ultrasonic similarities between the two anomalies. Ascites is occasionally present and is sometimes complicated by plural effusion, which is called Meig's syndrome. Occasionally the serum level of CA125 increases, which may lead to misdiagnosis of endometriosis or malignant tumors of the ovary (5, 6). This tumor occurs generally in elderly patients. In one study, 80.9% of the women were over 40 years old, and 49.0% of the patients were postmenopausal (7). Although rare, ovarian fibroma has been reported in young people too, in which the possibility of Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, must be considered (8–10). The choice treatment for ovarian fibroma is surgical removal, but the operative approach, whether laparoscopic or open has not been discussed sufficiently. Surgeons are reluctant to use laparoscopic surgical management, as the benign nature of the tumor cannot be definitely diagnosed preoperatively and it might be difficult to laparosco-pically resect the tumor safely with preservation of ovarian function, especially in young patients. In this case report, we presented a 24 year old patient with this tumor.

Case Presentation

A 24 year old Gravida 1 Para1 (G1P1) lady presented to the gynecology clinic of Rasoul-e-Akram hospital with pelvic discomfort for one year, which was recently exacerbated and dominantly located on right lower quadrant of the abdomen. The patient had no medical or surgical history, except for one Pfannenstiel-kerr cesarean section about 3 years ago. Primary physical examinations revealed a mobile solid mass of nearly 12 − 14 cm in diameter, which couldn't be differentiated from a uterine myoma. Pelvic ultrasonography showed a mixed echo mass of 117×83 mm in right adenexa, with vascular flow and pressure on posterior wall of the uterus. There was no sign of ascites or plural effusion. Preoperatively, tumor markers were assessed, which were within normal range and patient was scheduled for laparoscopic resection of the lesion on December 2012 in Rasoul-e-Akram hospital.

Procedure

Abdominal access was achieved by primary puncture with a 10 mm diameter umbilical cannula. Two other 5 mm diameter ancillary cannulas were introduced after creation of pneu-moperitoneum by nearly 2.5 L of carbon dioxide. A rigid video laparoscope was entered via umbilical port and two grasping forceps were introduced via two ancillary cannulas. During the procedure, the patient was placed in Trende-lenburg position. Several adhesion bundles were seen between uterus, adnexa, omentum and abdominal wall that were lysed. The right ovary contained a huge (10×15 cm), multiloculated, mobile and well circumscribed mass with laparoscopic features similar to a benign ovarian mass especially an ovarian fibroma or thecoma (Figure 1).
Figure 1

Primary laparoscopy feature of the tumor in a 24 year old patient, December 2012, Rasoul-e-Akram hospital, Tehran, Iran

Primary laparoscopy feature of the tumor in a 24 year old patient, December 2012, Rasoul-e-Akram hospital, Tehran, Iran We sent a sample for frozen section examination which proved the benign nature of the tumor, ovarian fibroma. Despite the size of the mass and tight adhesion of the capsule to the ovarian tissue, with a careful dissection and desiccation of the tumor, we could preserve the ovary during complete excision of the fibroma. After the excision of the ovarian fibroma, under direct vision of a 5 mm telescope, it was morcellated and removed through the umbilical port. Pneumoperitoneum was then deflated and ports were removed under direct vision. Finally, the rectus sheath and skin were closed with vicryl 2/0. Operating time from incision to closure was nearly 50 min, with no intraoperative complication. Postsurgical recovery was uneventful and the patient was discharged on the second day of surgery. There were also no immediate postoperative complications. Histopathologic examination revealed proliferation of spindle cells with blended nucleus in stratiform pattern with no pleomorfism or mitotic activity, which confirmed the diagnosis of ovarian fibroma (Figure 2).
Figure 2

Pathologic feature of the tumor in a 24 year old patient, December 2012, Rasoul-e-Akram hospital, Tehran, Iran

Pathologic feature of the tumor in a 24 year old patient, December 2012, Rasoul-e-Akram hospital, Tehran, Iran

Discussion

As occurred in our case, ovarian fibroma is often difficult to diagnose and the tumor is not often diagnosed accurately until the time of surgery. There are no characteristic symptoms and the ultrasonographic findings cannot easily distinguish ovarian fibroma from uterine myoma or even other types of ovarian mass. It has been reported that 34% of ovarian fibromas were misdiagnosed preoperatively as uterine myoma (11). On the other hand, up to 67% of these patients suffered from ascites, even in a very small-sized tumor. Also, high levels of serum CA125 in many of these cases may frequently cause misdiagnosis of malignant ovarian neoplasia (12, 13). Surgery is the unique treatment for ovarian fibroma. Salpingo-oophorectomy can be considered in perimenopausal or postmenopausal women, and cystectomy should be performed in youths. Previous reports showed the tendency to non-conservative approach in older ages, especially in laparoscopic surgery (7, 14). Eop Son et al. reported only 5 cases of ovarian cystetctomy with laparoscopic approach in a retrospective review on 47 women with confirmed ovarian fibromas. Others underwent more invasive approaches, in which the ovary was sacrificed. The median tumor diameter in laparoscopic group was 7 cm in one study (7). In other reported series of ovarian fibromas with mean diameter of 12.82 cm, no ovarian preservation was reported (14). Son recently reported a case of bilateral salpingo oophorectomy, or a large 10 cm ovarian fibroma, using a single port laparoscopic approach in a 64 year old woman (7). Ovarian preservation was mostly reported in younger patients and accompanied with Gorlin syndrome, which is present mostly with multiple and recurrent fibromas (8–10). For example, Ball et al. have reported 10 laparoscopic removals of ovarian fibromas, ranging from 3 mm to 7 cm in size (8). Seracchioli et al. reported laparoscopic removal of nine stony ovarian fibromas with ovarian tissue preservation, in a 22 year old girl (10). Although it was accepted to perform the surgery, either by laparotomy or laparoscopy, we recommend laparoscopy as the method of choice, especially in young patients, even in cases of very large ovarian fibromas. Comparative analysis of the outcomes between the laparoscopy and laparotomy group showed that laparoscopic surgery has several advantages including careful preservation of ovarian tissue, lower rate of adhesion-that is very important in young nulliparous patients (for preventing infertility due to tubal factor), shorter hospital stay, faster normalization of bowel activities, faster return to social life, less morbidity and better cosmetic results (7). Although there is a steady evolution towards less invasive techniques, laparoscopic approach to ovarian fibroma, especially in large tumors, may be challenging. However, we preserved nearly all normal ovarian tissue and safely removed the tumor by morcellator through a 10 mm trocar. In conclusion, we should not forget the role of laparoscopy as a diagnostic procedure even in suspicious cases of ovarian fibroma with solid tumor, ascites, and plural effusion.

Conclusion

In these cases, the benefits of using laparoscopy should not be neglected since we are able to change the laparoscopy to laparotomy in large malignant stage1 tumors.
  13 in total

1.  Ovarian fibromas in pediatric patients with basal cell nevus (Gorlin) syndrome.

Authors:  Allison Ball; Joan Wenning; Nancy Van Eyk
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-02       Impact factor: 1.814

2.  Conservative treatment of recurrent ovarian fibromas in a young patient affected by Gorlin syndrome.

Authors:  R Seracchioli; A Bagnoli; F M Colombo; S Missiroli; S Venturoli
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

Review 3.  How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.

Authors:  Alper Sevinc; Celalettin Camci; H Mehmet Turk; Suleyman Buyukberber
Journal:  Oncology       Date:  2003       Impact factor: 2.935

4.  Ovarian thecoma: clinicopathological analysis of 50 cases.

Authors:  Ana Lia Nocito; Sandra Sarancone; Carlos Bacchi; Tomás Tellez
Journal:  Ann Diagn Pathol       Date:  2007-10-03       Impact factor: 2.090

Review 5.  Ovarian fibroma: a review on the clinical characteristics, diagnostic difficulties, and management options of 23 cases.

Authors:  See Wai Leung; Pong Mo Yuen
Journal:  Gynecol Obstet Invest       Date:  2006-02-22       Impact factor: 2.031

Review 6.  Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature.

Authors:  A Morán-Mendoza; G Alvarado-Luna; G Calderillo-Ruiz; A Serrano-Olvera; C M López-Graniel; D Gallardo-Rincón
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

7.  Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas.

Authors:  Abdellatif Chechia; Leila Attia; Riadh Ben Temime; Taher Makhlouf; Abdelhamid Koubaa
Journal:  Am J Obstet Gynecol       Date:  2008-05-23       Impact factor: 8.661

8.  Ovarian fibroma--clinical and histopathological characteristics.

Authors:  V Sivanesaratnam; R Dutta; P Jayalakshmi
Journal:  Int J Gynaecol Obstet       Date:  1990-11       Impact factor: 3.561

9.  Ovarian fibroma: our experience of 34 cases.

Authors:  G Gargano; M De Lena; F Zito; G Fanizza; V Mattioli; F Schittulli
Journal:  Eur J Gynaecol Oncol       Date:  2003       Impact factor: 0.196

10.  Bilateral ovarian fibroma associated with Gorlin syndrome.

Authors:  Shahnaz Aram; Noushin Afshar Moghaddam
Journal:  J Res Med Sci       Date:  2009-01       Impact factor: 1.852

View more
  2 in total

1.  Large twisted ovarian fibroma in menopausal women: a case report.

Authors:  Majdouline Boujoual; Ihsan Hakimi; Jaouad Kouach; Mohamed Oukabli; Driss Rahali Moussaoui; Mohammed Dehayni
Journal:  Pan Afr Med J       Date:  2015-04-06

2.  Ovarian Fibroma Commonly Misdiagnosed as Uterine Leiomyoma.

Authors:  Ibrahim A Abdelazim; Mohannad Abu-Faza; Khaled Abdelrazek; Osama O Amer; Svetlana Shikanova; Gulmira Zhurabekova
Journal:  Gynecol Minim Invasive Ther       Date:  2019-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.